Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.

Amsterdam JD, Shults J, Brunswick DJ, Hundert M.

Bipolar Disord. 2004 Feb;6(1):75-81.

PMID:
14996144
2.

Antidepressant monotherapy for bipolar type II major depression.

Amsterdam JD, Brunswick DJ.

Bipolar Disord. 2003 Dec;5(6):388-95. Review.

PMID:
14636362
3.

Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.

Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM.

J Affect Disord. 2005 Jul;87(1):115-9. Review.

PMID:
15967235
4.

Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review.

Martinotti G, Sepede G, Signorelli M, Aguglia E, Di Giannantonio M.

Expert Opin Pharmacother. 2013 Jun;14(8):1065-75. doi: 10.1517/14656566.2013.783014. Epub 2013 Mar 26. Review.

PMID:
23527943
5.

[High-dose fluoxetine-induced mania. Review and case report].

Ruiz M, Vairo C, Matusevich D, Finkelsztein C.

Vertex. 2002 Jun-Aug;13(48):93-7. Review. Spanish.

PMID:
12192418
6.

Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review.

Brown ES, Bobadilla L, Rush AJ.

Bipolar Disord. 2001 Feb;3(1):23-9. Review.

PMID:
11256460
7.

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J; Stanley Foundation Bipolar Network.

Bipolar Disord. 2003 Dec;5(6):396-406. Review.

PMID:
14636363
8.

Antidepressant-induced mania: an overview of current controversies.

Goldberg JF, Truman CJ.

Bipolar Disord. 2003 Dec;5(6):407-20. Review.

PMID:
14636364
9.

The combination of olanzapine and fluoxetine in mood disorders.

Shelton RC.

Expert Opin Pharmacother. 2003 Jul;4(7):1175-83. Review.

PMID:
12831342
10.

SSRIs for premenstrual dysphoric disorder.

[No authors listed]

Drug Ther Bull. 2002 Sep;40(9):70-2. Review.

PMID:
12298224
11.

Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.

Croxtall JD, Scott LJ.

CNS Drugs. 2010 Mar;24(3):245-62. doi: 10.2165/11203830-000000000-00000. Review.

PMID:
20155998
12.

Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression.

Dubovsky SL.

Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):207-14. doi: 10.1517/17425255.2013.761206. Epub 2013 Jan 8. Review.

PMID:
23294052
13.

Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?

Chan RT, Rey JM, Hazell PL.

Med J Aust. 2002 Oct 21;177(8):448-51. Review.

PMID:
12381257
14.

Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

Chen J, Fang Y, Kemp DE, Calabrese JR, Gao K.

Curr Psychiatry Rep. 2010 Dec;12(6):512-21. doi: 10.1007/s11920-010-0157-z. Review.

PMID:
20878507
15.

Rate of switch from bipolar depression into mania after morning light therapy: A historical review.

Benedetti F.

Psychiatry Res. 2018 Mar;261:351-356. doi: 10.1016/j.psychres.2018.01.013. Epub 2018 Jan 9. Review.

PMID:
29348073

Supplemental Content

Support Center